R Jeffrey Neitz

7PUBLICATIONS
62CO-AUTHORS
Biomolecular modelling and designMajor global burdens of diseaseGene and molecular therapyCheminformatics and quantitative structure-activity relationshipsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 12, 2026
Large-scale prospective evaluation of co-folding across hundreds of Mac1-ligand complexes and three virtual screens.

|Jul 17, 2026
Discovery of non-nucleoside inhibitors of the enterovirus D68 3D polymerase through crystallographic fragment and high-throughput biochemical screening.

|Jan 09, 2026
Large scale prospective evaluation of co-folding across 557 Mac1-ligand complexes and three virtual screens.

Jongbin Kim, Galen J Correy, Brendan W Hall

|Nov 19, 2025
The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2.

Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy

|Apr 23, 2025
Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus MPro inhibitors with potent in vivo efficacy.

Tyler C Detomasi, Gilles Degotte, Sijie Huang

|Aug 16, 2024
The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2.

Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy

Pageof 2

Frequent Collaborators

6 joint publications

Adam R Renslo

6 joint publications

James S Fraser

6 joint publications

Brian K Shoichet

5 joint publications

Morgan E Diolaiti